Back to results
US 2003/0212019 A1Published application
Antisense modulation of cot oncogene expression
OwnerC Frank Bennett, Jacqueline Wyattinventors
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of cot oncogene. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding cot oncogene. Methods of using these compounds for modulation of cot oncogene expression and for treatment of diseases associated with expression of cot oncogene are provided.
Claims19
An antisense compound 8 to 30 nucleobases in length targeted to a nucleic acid molecule encoding cot oncogene, wherein said antisense compound specifically hybridizes with and inhibits the expression of cot oncogene.
Dependencies are inferred from the claim text.